Weiss Ratings Reaffirms Sell (E+) Rating for 22nd Century Group (NASDAQ:XXII)

Weiss Ratings reissued their sell (e+) rating on shares of 22nd Century Group (NASDAQ:XXII) in a research report sent to investors on Wednesday morning,Weiss Ratings reports.

Separately, StockNews.com downgraded 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Stock Down 3.1 %

NASDAQ:XXII opened at $3.15 on Wednesday. The business’s fifty day moving average price is $4.82 and its 200 day moving average price is $22.78. The firm has a market capitalization of $5.42 million, a price-to-earnings ratio of 0.00 and a beta of 1.57. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. 22nd Century Group has a 1-year low of $3.01 and a 1-year high of $581.85.

Institutional Investors Weigh In On 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP acquired a new position in shares of 22nd Century Group, Inc. (NASDAQ:XXII) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned approximately 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is currently owned by institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.